{"id":"https://openalex.org/W4288740467","doi":"https://doi.org/10.1016/s2213-8587(22)00188-7","title":"Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial","display_name":"Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial","alternate_titles":[],"publication_year":2022,"publication_date":"2022-07-30","ids":{"openalex":"https://openalex.org/W4288740467","doi":"https://doi.org/10.1016/s2213-8587(22)00188-7","pmid":"https://pubmed.ncbi.nlm.nih.gov/35914543"},"language":"en","primary_location":{"id":"doi:10.1016/s2213-8587(22)00188-7","doi":"https://doi.org/10.1016/s2213-8587(22)00188-7","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s2213-8587(22)00188-7","pdf_url":"https://www.sciencedirect.com/science/article/am/pii/S2213858722001887","source":{"id":"https://openalex.org/S2529869117","display_name":"The Lancet Diabetes & Endocrinology","issn_l":"2213-8587","issn":["2213-8587","2213-8595"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"The Lancet Diabetes &amp; Endocrinology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4288740467"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.sciencedirect.com/science/article/am/pii/S2213858722001887","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077189198","display_name":"Nobuya Inagaki","orcid":"https://orcid.org/0000-0001-8261-2593","observed_orcids":["https://orcid.org/0000-0001-8261-2593"]},"institutions":[{"id":"https://openalex.org/I22299242","display_name":"Kyoto University","ror":"https://ror.org/02kpeqv85","country_code":"JP","type":"education","lineage":["https://openalex.org/I22299242"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Nobuya Inagaki","raw_affiliation_strings":["Department of Diabetes, Endocrinology, and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Diabetes, Endocrinology, and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan","institution_ids":["https://openalex.org/I22299242"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018046892","display_name":"Masakazu Takeuchi","orcid":"https://orcid.org/0000-0003-3176-3118","observed_orcids":["https://orcid.org/0000-0003-3176-3118"]},"institutions":[{"id":"https://openalex.org/I4210108315","display_name":"Eli Lilly (Japan)","ror":"https://ror.org/01sv7f575","country_code":"JP","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210108315"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Masakazu Takeuchi","raw_affiliation_strings":["Japan Drug Development and Medical Affairs, Eli Lilly Japan, Kobe, Japan. Electronic address: takeuchi_masakazu@lilly.com","Japan Drug Development and Medical Affairs, Eli Lilly Japan, Kobe, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Drug Development and Medical Affairs, Eli Lilly Japan, Kobe, Japan. Electronic address: takeuchi_masakazu@lilly.com","institution_ids":["https://openalex.org/I4210108315"]},{"raw_affiliation_string":"Japan Drug Development and Medical Affairs, Eli Lilly Japan, Kobe, Japan","institution_ids":["https://openalex.org/I4210108315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065510246","display_name":"Tomonori Oura","orcid":"https://orcid.org/0000-0003-0872-8576","observed_orcids":["https://orcid.org/0000-0003-0872-8576"]},"institutions":[{"id":"https://openalex.org/I4210108315","display_name":"Eli Lilly (Japan)","ror":"https://ror.org/01sv7f575","country_code":"JP","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210108315"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomonori Oura","raw_affiliation_strings":["Japan Drug Development and Medical Affairs, Eli Lilly Japan, Kobe, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Drug Development and Medical Affairs, Eli Lilly Japan, Kobe, Japan","institution_ids":["https://openalex.org/I4210108315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082595973","display_name":"Takeshi Imaoka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108315","display_name":"Eli Lilly (Japan)","ror":"https://ror.org/01sv7f575","country_code":"JP","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210108315"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takeshi Imaoka","raw_affiliation_strings":["Japan Drug Development and Medical Affairs, Eli Lilly Japan, Kobe, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Drug Development and Medical Affairs, Eli Lilly Japan, Kobe, Japan","institution_ids":["https://openalex.org/I4210108315"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052412166","display_name":"Yutaka Seino","orcid":"https://orcid.org/0000-0002-1099-7989","observed_orcids":["https://orcid.org/0000-0002-1099-7989"]},"institutions":[{"id":"https://openalex.org/I2800996768","display_name":"Kansai Electric Power (Japan)","ror":"https://ror.org/03xrg8731","country_code":"JP","type":"company","lineage":["https://openalex.org/I2800996768"]},{"id":"https://openalex.org/I4210123101","display_name":"Kansai Electric Power Hospital","ror":"https://ror.org/02srt1z47","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210123101"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yutaka Seino","raw_affiliation_strings":["Kansai Electric Power Hospital, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kansai Electric Power Hospital, Osaka, Japan","institution_ids":["https://openalex.org/I2800996768","https://openalex.org/I4210123101"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5018046892"],"corresponding_institution_ids":["https://openalex.org/I4210108315"],"apc_list":{"value":6000,"currency":"USD","value_usd":6000},"apc_paid":null,"fwci":30.7163,"has_fulltext":false,"cited_by_count":251,"citation_normalized_percentile":{"value":0.99876219,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"10","issue":"9","first_page":"623","last_page":"633"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tirzepatide","display_name":"tirzepatide","score":0.9739999771118164},{"id":"https://openalex.org/keywords/dulaglutide","display_name":"dulaglutide","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9919999837875366},{"id":"https://openalex.org/keywords/gip-glp-1-receptor-agonist","display_name":"GIP/GLP-1 receptor agonist","score":0.8289999961853027},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.7289999723434448},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8489999771118164},{"id":"https://openalex.org/keywords/treatment-naive-patients","display_name":"treatment-naive patients","score":0.6660000085830688},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.7390000224113464},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4880000054836273},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6370000243186951},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.4449999928474426},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.328000009059906},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.6949999928474426}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9774824380874634},{"id":"https://openalex.org/C2779829264","wikidata":"https://www.wikidata.org/wiki/Q21011228","display_name":"Dulaglutide","level":5,"score":0.9165887832641602},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.804360032081604},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.4778197109699249},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.4660792052745819},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.45188793540000916},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4222589433193207},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.24393588304519653},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.11345309019088745},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.09173363447189331},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.08100318908691406},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000098860","descriptor_name":"Tirzepatide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005749","descriptor_name":"Gastric Inhibitory Polypeptide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007141","descriptor_name":"Immunoglobulin Fc Fragments","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s2213-8587(22)00188-7","doi":"https://doi.org/10.1016/s2213-8587(22)00188-7","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s2213-8587(22)00188-7","pdf_url":"https://www.sciencedirect.com/science/article/am/pii/S2213858722001887","source":{"id":"https://openalex.org/S2529869117","display_name":"The Lancet Diabetes & Endocrinology","issn_l":"2213-8587","issn":["2213-8587","2213-8595"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"The Lancet Diabetes &amp; Endocrinology","raw_type":"journal-article"},{"id":"pmid:35914543","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35914543","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The lancet. Diabetes & endocrinology","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":{"id":"doi:10.1016/s2213-8587(22)00188-7","doi":"https://doi.org/10.1016/s2213-8587(22)00188-7","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s2213-8587(22)00188-7","pdf_url":"https://www.sciencedirect.com/science/article/am/pii/S2213858722001887","source":{"id":"https://openalex.org/S2529869117","display_name":"The Lancet Diabetes & Endocrinology","issn_l":"2213-8587","issn":["2213-8587","2213-8595"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"The Lancet Diabetes &amp; Endocrinology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320333624","display_name":"Eli Lilly Japan","ror":"https://ror.org/01sv7f575"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1582261481","https://openalex.org/W1944521216","https://openalex.org/W1951367122","https://openalex.org/W1974573250","https://openalex.org/W1987784412","https://openalex.org/W1998401806","https://openalex.org/W2012425163","https://openalex.org/W2034667874","https://openalex.org/W2052697465","https://openalex.org/W2082213840","https://openalex.org/W2120568116","https://openalex.org/W2147817624","https://openalex.org/W2574032118","https://openalex.org/W2743930068","https://openalex.org/W2791728731","https://openalex.org/W2895135221","https://openalex.org/W2909601957","https://openalex.org/W3017978130","https://openalex.org/W3093042356","https://openalex.org/W3112461052","https://openalex.org/W3161292733","https://openalex.org/W3175369690","https://openalex.org/W3177122952","https://openalex.org/W3177393241","https://openalex.org/W3191712049","https://openalex.org/W3205201678","https://openalex.org/W4210940103","https://openalex.org/W4211009683","https://openalex.org/W4288735703"],"related_works":["https://openalex.org/W4236838467","https://openalex.org/W4288735703","https://openalex.org/W3177393241","https://openalex.org/W4300689830","https://openalex.org/W3173376942","https://openalex.org/W4324120940","https://openalex.org/W1906367066","https://openalex.org/W4396742226","https://openalex.org/W4286310814","https://openalex.org/W3201298688"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4288740467","counts_by_year":[{"year":2026,"cited_by_count":56},{"year":2025,"cited_by_count":65},{"year":2024,"cited_by_count":62},{"year":2023,"cited_by_count":54},{"year":2022,"cited_by_count":14}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2022-07-30T00:00:00"}
